Organism: human
Disease: Alzheimer disease
OrganismPart: dentate terminal zone of the perforant path
OrganismPart: molecular layer of the dentate gyrus
OrganismPart: outer molecular layer of the dentate gyrus
MaterialType: brain tissue
SampleTreatment: frozen hippocampal tissue
SampleTreatment: cryosectioned
SampleTreatment: fixed in 75% ethanol
SampleTreatment: stained with toluidine blue
SampleTreatment: microdissected using LMD
SampleTreatment: lysed in SDS buffer
SampleTreatment: heated at 95 degreesC
SampleTreatment: sonicated for 1 min
SampleTreatment: centrifuged at 13,000 x g
SampleTreatment: alkylated with chloroacetamide
SampleTreatment: SP3 clean-up
SampleTreatment: digested with Lys-C and trypsin
SampleTreatment: TMT10plex labeling
SampleTreatment: solid phase extraction cleanup
ReductionReagent: DTT
AlkylationReagent: chloroacetamide
CleavageAgent: Lys-C
CleavageAgent: trypsin
Label: TMT10plex (lysine and N-termini)
Label: carbamidomethyl (C)
Label: oxidation (M)
Modification: carbamidomethyl (C)
Modification: oxidation (M)
EnrichmentMethod: HiRIEF
FractionationMethod: isoelectric focusing with IPG drystrip
NumberOfFractions: 72
Separation: UltiMate 3000 RSLCnano System
Separation: Acclaim PepMap 100 C18, 75 μm x 2 cm
Separation: Easy spray PepMap RSLC, C18, 2 μm, 75 μm x 50 cm
GradientTime: ~50 min gradient up to 40% solvent B
Instrument: Q-Exactive-HF mass spectrometer
IonizationType: electrospray ionization
AcquisitionMethod: data-dependent acquisition
FragmentationMethod: higher-energy collisional dissociation
CollisionEnergy: 30–40% normalized collision energy
MS2MassAnalyzer: Orbitrap
PrecursorMassTolerance: 10 ppm
FragmentMassTolerance: 0.02 Da
AssayName: proteomic analysis of perforant path
FactorValue: disease state (AD vs control)
NumberOfSamples: 10 biological samples (5 AD, 5 control)